The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HTHT, DY, ALGN, NKTR and SYF
NEW YORK, Dec. 05, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Huazhu Group Limited (NASDAQ: HTHT) Class Period: May 14, 2018 to August 28, 2018 Lead Plaintiff Deadline: December 7, 2018
Huazhu Group Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate security measures to protect customer information; (2) as a result of the foregoing, the Company would be susceptible to increased litigation risk and higher expenses; (3) as a result of the foregoing, the Company’s goodwill would potentially suffer, leading to lower revenues; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
Get additional information about the HTHT lawsuit: http://www.kleinstocklaw.com/pslra-1/huazhu-group-limited-loss-submission-form?wire=3
Dycom Industries, Inc. (NYSE: DY) Class Period: November 20, 2017 to August 10, 2018 Lead Plaintiff Deadline: December 24, 2018
The lawsuit alleges that throughout the class period, Dycom Industries, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Dycom’s large projects were highly dependent on permitting and tactical considerations, (ii) Dycom was facing great uncertainties related to permitting issues; (iii) said uncertainties would expose Dycom to near-term margin pressure and absorption issues, and (iv) as a result of the foregoing, Defendants’ statements about Dycom’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
Get additional information about the DY lawsuit: http://www.kleinstocklaw.com/pslra-1/loss-submission-form-2?wire=3
Align Technology, Inc. (NASDAQGS: ALGN) Class Period: July 25, 2018 to October 24, 2018 Lead Plaintiff Deadline: January 4, 2019
The complaint alleges Align Technology, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company would offer higher discounts to promote Invisalign; (2) the promotions would materially impact revenue; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
On October 24, 2018, Align Technology issued a press release announcing its Q3 2018 financial results. Therein, the Company disclosed a more than 6% decrease in its Invisalign Average Selling Price (“ASP”). On the same day, the Company also announced that its Chief Marketing Officer would “reduce his responsibilities and transition to a part-time position.” On this news, Align Technology’s share price shares fell $58.76 to close at $232.07 on October 25, 2018, thereby injuring investors.
Get additional information about the ALGN lawsuit: http://www.kleinstocklaw.com/pslra-1/align-technology-inc-loss-submission-form?wire=3
Nektar Therapeutics (NASDAQ: NKTR) Class Period: November 11, 2017 to October 2, 2018 Lead Plaintiff Deadline: December 31, 2018
The lawsuit alleges Nektar Therapeutics made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) prior studies which attempted to pegylate IL-2 failed; (2) the extended half-life of the Company’s lead I-O candidate, NKTR-214, was unlikely to result in efficacy and created additional high-dosing safety concerns; (3) NKTR-214 was less effective than IL-2 alone; (4) the combination of NKTR-214 with nivolumab has yet to demonstrate significant positive results; and (5) as a result, Nektar’s public statements as set forth above were materially false and misleading at all relevant times.
Get additional information about the NKTR lawsuit: http://www.kleinstocklaw.com/pslra-1/nektar-therapeutics-loss-submission-form?wire=3
Synchrony Financial (NYSE: SYF) Class Period: October 21, 2016 to November 1, 2018 Lead Plaintiff Deadline: January 2, 2019
The complaint alleges that during the Class Period, Synchrony falsely represented that its consistent and disciplined underwriting practices had led to a higher quality loan portfolio than those of its competitors. In truth, Synchrony relaxed its underwriting standards and increasingly offered private-label credit cards to riskier borrowers to sustain growth. The truth about Synchrony’s credit standards began to be revealed on April 28, 2017, when the Company announced disappointing first quarter 2017 earnings driven by poor loan performance. Following this disclosure, the Company represented that it had tightened credit standards, but falsely characterized those underwriting changes as modest. In fact, the Company had made significant modifications to its underwriting policies, but concealed that these modifications were damaging its relationships with its retail partners, including Walmart.
Get additional information about the SYF lawsuit: http://www.kleinstocklaw.com/pslra-1/synchrony-financial-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.